Hanmi Science Co., Ltd. (KRX:008930)
South Korea · Delayed Price · Currency is KRW 50,900
-200 (-0.39%)
Sep 17, 2026, 3:30 PM KST
Hanmi Science Market Cap
Hanmi Science has a market cap or net worth of 3.45 trillion as of September 17, 2026. Its market cap has increased by 27.32% in one year.
Market Cap
3.45T
Enterprise Value
3.53T
Revenue
1.41T
Ranking
n/a
PE Ratio
22.86
Stock Price
50,900.00
ChartMarket Cap Chart
Since August 28, 1995, Hanmi Science's market cap has increased from 36.00B to 3.45T, an increase of 9,479.28%. That is a compound annual growth rate of 15.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 3.45T | 40.49% |
| Dec 30, 2025 | 2.45T | 23.09% |
| Dec 30, 2024 | 1.99T | -25.17% |
| Dec 28, 2023 | 2.66T | 20.78% |
| Dec 29, 2022 | 2.21T | -39.49% |
| Dec 30, 2021 | 3.65T | -27.37% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 65.66T |
| Celltrion | 42.60T |
| ALTEOGEN | 18.10T |
| Samsung Epis Holdings | 8.27T |
| HLB Co., Ltd. | 4.31T |
| Sam Chun Dang Pharm. | 3.69T |
| PharmaResearch | 3.50T |
| ABL Bio | 3.32T |